Diligence memo · auto-generated · as of July 2, 2026

Remedy Diagnostics LLC

Remedy Diagnostics LLC looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Remedy Diagnostics LLC operates in Medical Devices, based in HOUSTON.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Remedy Diagnostics LLC has raised $345K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $345K on 2023-01-27.

Most recent recorded round closed around 2023-01-27.

Valuation (modeled)modeled

Provath models Remedy Diagnostics LLC at approximately $3.2M (range $207K–$17M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.15× the median modeled value of Pre-Seed Medical Devices companies in 2022–2024 (29 peers) — value vs value, same stage and era. Within the normal band (115% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 3.4 yr ago; this sector typically re-raises about every 16 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 25% of Medical Devices peers (233 compared).

Modeled value ranks above 31% of those peers.

Closest niche peers: Turbett Surgical, Inc., Owensboro Ambulatory Surgical Facility Ltd, Seashore Surgical Institute, L.L.C., Hera Diagnostics Corp, Hawkeye Surgical Lighting.

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.